OBIO
Orchestra BioMed Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.65
+3.67%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 702.47x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 11.54x
- Price / sales
- 10.62x
- Price / cash flow
- -5.82x
Enterprise value
- Enterprise value
- $310.5M
- EV / sales
- 9.71x
- EV / EBITDA
- -5.44x
- EV / EBIT
- -5.35x
- Market cap
- $339.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026